Does the media favor CON or LMRI?

In the previous week, Concentra Group Holdings Parent and Concentra Group Holdings Parent both had 3 articles in the media. Concentra Group Holdings Parent's average media sentiment score of 0.91 beat Lumexa Imaging's score of 0.45 indicating that Concentra Group Holdings Parent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Concentra Group Holdings Parent 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor PRVA or LMRI?

In the previous week, Privia Health Group and Privia Health Group both had 3 articles in the media. Privia Health Group's average media sentiment score of 1.64 beat Lumexa Imaging's score of 0.45 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Lumexa Imaging 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor LMRI or OPCH?

In the previous week, Option Care Health had 6 more articles in the media than Lumexa Imaging. MarketBeat recorded 9 mentions for Option Care Health and 3 mentions for Lumexa Imaging. Option Care Health's average media sentiment score of 1.63 beat Lumexa Imaging's score of 0.45 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Option Care Health 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable valuation & earnings, LMRI or GRAL?

Lumexa Imaging has higher revenue and earnings than GRAIL. Lumexa Imaging is trading at a lower price-to-earnings ratio than GRAIL, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lumexa Imaging $1.03B 1.03 -$47.10M -$0.59 N/A GRAIL $156.12M 18.35 -$408.35M -$10.37 N/A

Is LMRI or GRAL more profitable?

Lumexa Imaging has a net margin of 0.00% compared to GRAIL's net margin of -253.22%. Lumexa Imaging's return on equity of 0.00% beat GRAIL's return on equity. Company Net Margins Return on Equity Return on Assets Lumexa Imaging N/A N/A N/A GRAIL -253.22% -16.42% -14.34%

Does the media favor LMRI or GRAL?

In the previous week, GRAIL had 35 more articles in the media than Lumexa Imaging. MarketBeat recorded 38 mentions for GRAIL and 3 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.45 beat GRAIL's score of 0.13 indicating that Lumexa Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GRAIL 3 Very Positive mention(s) 1 Positive mention(s) 33 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, LMRI or PGNY?

Progyny has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lumexa Imaging $1.03B 1.03 -$47.10M -$0.59 N/A Progyny $1.29B 1.91 $58.52M $0.77 41.03

Does the media prefer LMRI or PGNY?

In the previous week, Progyny had 7 more articles in the media than Lumexa Imaging. MarketBeat recorded 10 mentions for Progyny and 3 mentions for Lumexa Imaging. Progyny's average media sentiment score of 0.83 beat Lumexa Imaging's score of 0.45 indicating that Progyny is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Progyny 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Lumexa Imaging (LMRI) Competitors

$11.05 +0.12 (+1.10%)

Closing price 07/27/2026 04:00 PM Eastern

Extended Trading

$11.00 -0.04 (-0.41%)

As of 09:06 AM Eastern

Compare

LMRI vs. CON, PRVA, OPCH, GRAL, and PGNY

Should you buy Lumexa Imaging stock or one of its competitors? MarketBeat compares Lumexa Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lumexa Imaging include Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Option Care Health (OPCH), GRAIL (GRAL), and Progyny (PGNY). These companies are all part of the "healthcare" industry.

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Concentra Group Holdings Parent (NYSE:CON) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Concentra Group Holdings Parent presently has a consensus target price of $31.40, indicating a potential downside of 1.66%. Lumexa Imaging has a consensus target price of $16.00, indicating a potential upside of 44.80%. Given Lumexa Imaging's higher probable upside, analysts plainly believe Lumexa Imaging is more favorable than Concentra Group Holdings Parent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concentra Group Holdings Parent	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Concentra Group Holdings Parent has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concentra Group Holdings Parent	$2.16B	1.89	$166.41M	$1.39	22.97
Lumexa Imaging	$1.03B	1.03	-$47.10M	-$0.59	N/A

In the previous week, Concentra Group Holdings Parent and Concentra Group Holdings Parent both had 3 articles in the media. Concentra Group Holdings Parent's average media sentiment score of 0.91 beat Lumexa Imaging's score of 0.45 indicating that Concentra Group Holdings Parent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Concentra Group Holdings Parent	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Concentra Group Holdings Parent has a net margin of 7.97% compared to Lumexa Imaging's net margin of 0.00%. Concentra Group Holdings Parent's return on equity of 47.14% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Concentra Group Holdings Parent	7.97%	47.14%	6.48%
Lumexa Imaging	N/A	N/A	N/A

Summary

Concentra Group Holdings Parent beats Lumexa Imaging on 11 of the 13 factors compared between the two stocks.

How does Lumexa Imaging compare to Privia Health Group?

Privia Health Group (NASDAQ:PRVA) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

In the previous week, Privia Health Group and Privia Health Group both had 3 articles in the media. Privia Health Group's average media sentiment score of 1.64 beat Lumexa Imaging's score of 0.45 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Lumexa Imaging	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Privia Health Group has a net margin of 0.97% compared to Lumexa Imaging's net margin of 0.00%. Privia Health Group's return on equity of 2.81% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
Lumexa Imaging	N/A	N/A	N/A

Privia Health Group currently has a consensus target price of $31.15, indicating a potential upside of 26.28%. Lumexa Imaging has a consensus target price of $16.00, indicating a potential upside of 44.80%. Given Lumexa Imaging's higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than Privia Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.71
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

94.5% of Privia Health Group shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by insiders. Comparatively, 0.7% of Lumexa Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Privia Health Group has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.25B	1.38	$22.92M	$0.16	154.19
Lumexa Imaging	$1.03B	1.03	-$47.10M	-$0.59	N/A

Summary

Privia Health Group beats Lumexa Imaging on 13 of the 15 factors compared between the two stocks.

How does Lumexa Imaging compare to Option Care Health?

Lumexa Imaging (NASDAQ:LMRI) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

Option Care Health has a net margin of 3.64% compared to Lumexa Imaging's net margin of 0.00%. Option Care Health's return on equity of 18.17% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Option Care Health	3.64%	18.17%	7.16%

98.1% of Option Care Health shares are held by institutional investors. 0.7% of Lumexa Imaging shares are held by company insiders. Comparatively, 1.7% of Option Care Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Option Care Health has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$1.03B	1.03	-$47.10M	-$0.59	N/A
Option Care Health	$5.67B	0.60	$207.59M	$1.29	16.91

In the previous week, Option Care Health had 6 more articles in the media than Lumexa Imaging. MarketBeat recorded 9 mentions for Option Care Health and 3 mentions for Lumexa Imaging. Option Care Health's average media sentiment score of 1.63 beat Lumexa Imaging's score of 0.45 indicating that Option Care Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Option Care Health	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Lumexa Imaging currently has a consensus target price of $16.00, indicating a potential upside of 44.80%. Option Care Health has a consensus target price of $30.08, indicating a potential upside of 37.90%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts plainly believe Lumexa Imaging is more favorable than Option Care Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Option Care Health	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Option Care Health beats Lumexa Imaging on 12 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to GRAIL?

Lumexa Imaging (NASDAQ:LMRI) and GRAIL (NASDAQ:GRAL) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Lumexa Imaging has higher revenue and earnings than GRAIL. Lumexa Imaging is trading at a lower price-to-earnings ratio than GRAIL, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$1.03B	1.03	-$47.10M	-$0.59	N/A
GRAIL	$156.12M	18.35	-$408.35M	-$10.37	N/A

In the previous week, GRAIL had 35 more articles in the media than Lumexa Imaging. MarketBeat recorded 38 mentions for GRAIL and 3 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.45 beat GRAIL's score of 0.13 indicating that Lumexa Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GRAIL	3 Very Positive mention(s)	1 Positive mention(s)	33 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Lumexa Imaging has a net margin of 0.00% compared to GRAIL's net margin of -253.22%. Lumexa Imaging's return on equity of 0.00% beat GRAIL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
GRAIL	-253.22%	-16.42%	-14.34%

Lumexa Imaging presently has a consensus price target of $16.00, indicating a potential upside of 44.80%. GRAIL has a consensus price target of $67.78, indicating a potential upside of 1.51%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, equities analysts clearly believe Lumexa Imaging is more favorable than GRAIL.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
GRAIL	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.30

Summary

Lumexa Imaging beats GRAIL on 10 of the 14 factors compared between the two stocks.

How does Lumexa Imaging compare to Progyny?

Lumexa Imaging (NASDAQ:LMRI) and Progyny (NASDAQ:PGNY) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

Lumexa Imaging currently has a consensus price target of $16.00, indicating a potential upside of 44.80%. Progyny has a consensus price target of $33.25, indicating a potential upside of 5.25%. Given Lumexa Imaging's higher probable upside, analysts clearly believe Lumexa Imaging is more favorable than Progyny.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Progyny	0 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.92

Progyny has a net margin of 5.23% compared to Lumexa Imaging's net margin of 0.00%. Progyny's return on equity of 13.34% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Progyny	5.23%	13.34%	9.03%

Progyny has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$1.03B	1.03	-$47.10M	-$0.59	N/A
Progyny	$1.29B	1.91	$58.52M	$0.77	41.03

94.9% of Progyny shares are owned by institutional investors. 0.7% of Lumexa Imaging shares are owned by company insiders. Comparatively, 9.9% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Progyny had 7 more articles in the media than Lumexa Imaging. MarketBeat recorded 10 mentions for Progyny and 3 mentions for Lumexa Imaging. Progyny's average media sentiment score of 0.83 beat Lumexa Imaging's score of 0.45 indicating that Progyny is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Progyny	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Progyny beats Lumexa Imaging on 14 of the 15 factors compared between the two stocks.

Get Lumexa Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LMRI vs. The Competition

Export

Metric	Lumexa Imaging	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$1.06B	$1.98B	$16.95B	$12.16B
Dividend Yield	N/A	N/A	5.18%	9.43%
P/E Ratio	-18.73	26.23	20.09	23.74
Price / Sales	1.03	6.29	35.49	76.07
Price / Cash	31.44	108.75	79.87	46.67
Price / Book	1.78	31.47	12.80	6.16
Net Income	-$47.10M	-$30.36M	-$15.57M	$331.26M
7 Day Performance	-0.72%	8.69%	-0.66%	-0.72%
1 Month Performance	-8.68%	17.93%	24.18%	-2.52%
1 Year Performance	N/A	N/A	213.41%	14.76%

Lumexa Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LMRI Lumexa Imaging	4.2627 of 5 stars	$11.05 +1.1%	$16.00 +44.8%	N/A	$1.06B	$1.03B	N/A	5,019
CON Concentra Group Holdings Parent	3.5642 of 5 stars	$31.60 +3.4%	$31.40 -0.6%	+62.1%	$3.91B	$2.16B	22.73	13,133
PRVA Privia Health Group	4.6792 of 5 stars	$27.22 -3.1%	$31.15 +14.5%	+25.2%	$3.54B	$2.12B	170.14	1,226	Positive News High Trading Volume
OPCH Option Care Health	4.7532 of 5 stars	$22.10 +0.0%	$30.54 +38.2%	-26.5%	$3.47B	$5.65B	17.13	8,266	News Coverage Positive News Upcoming Earnings
GRAL GRAIL	1.1163 of 5 stars	$71.96 -3.2%	$67.78 -5.8%	+65.7%	$3.19B	$147.17M	N/A	1,360

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LMRI) was last updated on 7/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lumexa Imaging (LMRI) Competitors

LMRI vs. CON, PRVA, OPCH, GRAL, and PGNY

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Summary

How does Lumexa Imaging compare to Privia Health Group?

Summary

How does Lumexa Imaging compare to Option Care Health?

Summary

How does Lumexa Imaging compare to GRAIL?

Summary

How does Lumexa Imaging compare to Progyny?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lumexa Imaging (LMRI) Competitors

LMRI vs. CON, PRVA, OPCH, GRAL, and PGNY

How does Lumexa Imaging compare to Concentra Group Holdings Parent?

Do analysts prefer CON or LMRI?

Which has preferable valuation and earnings, CON or LMRI?

Does the media favor CON or LMRI?

Is CON or LMRI more profitable?

Summary

How does Lumexa Imaging compare to Privia Health Group?

Does the media favor PRVA or LMRI?

Is PRVA or LMRI more profitable?

Do analysts prefer PRVA or LMRI?

Do insiders and institutionals believe in PRVA or LMRI?

Which has stronger earnings & valuation, PRVA or LMRI?

Summary

How does Lumexa Imaging compare to Option Care Health?

Is LMRI or OPCH more profitable?

Do insiders & institutionals believe in LMRI or OPCH?

Which has higher earnings & valuation, LMRI or OPCH?

Does the media favor LMRI or OPCH?

Do analysts rate LMRI or OPCH?

Summary

How does Lumexa Imaging compare to GRAIL?

Which has preferable valuation & earnings, LMRI or GRAL?

Does the media favor LMRI or GRAL?

Is LMRI or GRAL more profitable?

Do analysts recommend LMRI or GRAL?

Summary

How does Lumexa Imaging compare to Progyny?

Do analysts prefer LMRI or PGNY?

Is LMRI or PGNY more profitable?

Which has stronger valuation and earnings, LMRI or PGNY?

Do institutionals & insiders believe in LMRI or PGNY?

Does the media prefer LMRI or PGNY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools